ArriVentPress Releases ArriVent Biopharma Launches with Up To $150M in Series A Financing and Strategic Licensing Agreement for Clinical-Stage Oncology Asset Funds will be used to build ArriVent’s portfolio of innovative in-licensed assets for global development…Amy HirschJune 30, 2021
